1. Health Canada. Health Canada assessing NDMA in ranitidine, 2019 September 13. https://recalls-rappels.canada.ca/en/alert-recall/health-canada-assessing-ndma-ranitidine. Accessed November 1, 2022.
2. U.S. Food & Drug Administration. Statement alerting patients and health care professionals of NDMA found in samples of ranitidine, 2019 September 13. https://www.fda.gov/news-events/press-announcements/statement-alerting-patients-and-health-care-professionals-ndma-found-samples-ranitidine. Accessed November 1, 2022.
3. Health Canada. Ranitidine products recalled because of a nitrosamine impurity, 2022 March 11. https://recalls-rappels.canada.ca/en/alert-recall/ranitidine-products-recalled-because-nitrosamine-impurity. Accessed December 19, 2022.
4. U.S. Food & Drug Administration. FDA Updates and Press Announcements on NDMA in Zantac (ranitidine), 2020 April 16. https://www.fda.gov/drugs/drug-safety-and-availability/fda-updates-and-press-announcements-ndma-zantac-ranitidine. Accessed December 19, 2022.
5. Health Canada. Drug Shortages Canada, 2023. https://www.drugshortagescanada.ca/. Accessed November 23, 2022.